MedPath

Retrospective Investigation of CT and MRI Imaging Features of Tubulocystic Renal Cell Carcinoma.

Not Applicable
Conditions
Tubulocystic Renal Cell Carcinoma(TC-RCC), Collecting Duct Carcinoma(CDC), Papillary Renal Cell Carcinoma(P-RCC), Multilocular Cystic Renal Cell Carcinoma(MC-RCC), Cystic Nephroma(CN), Mixed Epithelial and Stromal Tumor of Kidney(MEST)
Registration Number
JPRN-UMIN000023309
Lead Sponsor
Institute and Graduate School of Biomedical Sciences. Hiroshima University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1. Pts. before surgery for renal tumors receiving chemotherapy surgery within six months ago. 2. Pts. receiving chemotherapy for renal tumors after CT or MRI. 3. Double registration of the same patient is prohibited. 4. Any other pts. who are determined ineligible for this study by investigators.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Imaging features of Tubulocystic Renal Cell Carcinoma in comparison with Collecting Duct Carcinoma, Papillary Renal Cell Carcinoma, Multilocular Cystic Renal Cell Carcinoma, Cystic nephroma, and Mixed Epithelial and Stromal Tumor of Kidney. Descriptively summarize the following evaluation items on CT and MRI images among tumors; diameter, borderline, internal structure, necrosis, bleeding, invasion, calcification, venous tumor thrombus, dynamic pattern, CT index, Low intensity of T2, T2 STAR or SWI, observation of T1 in-opposed phase, observation of DWI, pathological staging, Bosniak classfication
Secondary Outcome Measures
NameTimeMethod
ot applicable.
© Copyright 2025. All Rights Reserved by MedPath